Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001923794-26-000002

Chief Technology Officer sold 7,000 shares at $10.02 ($70,151)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2026-06-29 Sale 10b5-1 −7,000 $10.02 $70,151 83,865 D
Open-market sales · 7,000 sh · avg $10.02 · $70,151
Loading xslF345X06/ownership.xml…